The Wegovy prescribing information states explicitly: "Discontinue WEGOVY at least 2 months before a planned pregnancy" because of the long half-life of semaglutide (approximately 7 days, requiring roughly 5 half-lives for washout) [3]
Noticeable improvement in skin hydration and softness Reduction in redness and skin sensitivity Barrier proteins beginning to strengthen Subtle "glow from within" that precedes visible changes Reactive or damaged skin shows the fastest early response By weeks 34, the first visible changes become apparent
It also has anti-inflammatory effects, meaning ALA offers protection against diabetic neuropathy, metabolic syndrome, vision loss, skin changes and other age-related problems
Key points Xerostomia most common
Heroin, an opioid, primarily modulates G protein-coupled receptor activity and affects neuronal excitability and reward pathways